{"title": "Virologists discover safer potential Zika vaccine", "title_detail": {"type": "text/plain", "language": null, "base": "https://www.sciencedaily.com/rss/health_medicine/vaccines.xml", "value": "Virologists discover safer potential Zika vaccine"}, "links": [{"rel": "alternate", "type": "text/html", "href": "https://www.sciencedaily.com/releases/2018/12/181220104733.htm"}], "link": "https://www.sciencedaily.com/releases/2018/12/181220104733.htm", "summary": "In mouse trials, a vaccine based on recombinant adenovirus protected against Zika without evidence of antibodies. Reports have shown Zika antibodies can worsen Dengue virus infection.", "summary_detail": {"type": "text/html", "language": null, "base": "https://www.sciencedaily.com/rss/health_medicine/vaccines.xml", "value": "In mouse trials, a vaccine based on recombinant adenovirus protected against Zika without evidence of antibodies. Reports have shown Zika antibodies can worsen Dengue virus infection."}, "media_thumbnail": [{"url": "https://www.sciencedaily.com/images/2018/12/181220104733-large.jpg", "height": "200", "width": "300"}], "href": "", "published": "Thu, 20 Dec 2018 10:47:33 EST", "published_parsed": [2018, 12, 20, 15, 47, 33, 3, 354, 0], "id": "https://www.sciencedaily.com/releases/2018/12/181220104733.htm", "guidislink": false}